Dark
Light
System
Security
THERAVANCE BIOPHARMA INC
THERAVANCE BIOPHARMA INC. Institutional holdings reported to the SEC.

Institutional Holders (2016Q4)
Portfolio Summary: 20 Institutional holders with a total value of $246,874,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 LINDEN ADVISORS LP 42,667,000 48,959,000 19.83% PRN
2 HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,500,000 36,304,000 14.71% PRN
3 BAUPOST GROUP LLC/MA 30,000,000 34,059,000 13.80% PRN
4 WOLVERINE ASSET MANAGEMENT LLC 21,000,000 24,181,000 9.79% PRN
5 EcoR1 Capital, LLC 17,000,000 19,327,000 7.83% PRN
6 CITADEL ADVISORS LLC 12,500,000 14,393,000 5.83% PRN
7 OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 10,000,000 11,517,000 4.67% PRN
8 BlueCrest Capital Management Ltd 9,167,000 10,570,000 4.28% PRN
9 TENOR CAPITAL MANAGEMENT Co., L.P. 9,000,000 10,407,000 4.22% PRN
10 FMR LLC 7,000,000 7,958,000 3.22% PRN
11 Verition Fund Management LLC 6,000,000 6,851,000 2.78% PRN
12 CSS LLC/IL 4,000,000 4,594,000 1.86% PRN
13 Weiss Asset Management LP 3,000,000 3,446,000 1.40% PRN
14 Tetragon Partners GP Ltd 2,500,000 2,885,000 1.17% PRN
15 SSI INVESTMENT MANAGEMENT LLC 2,000,000 2,295,000 0.93% PRN
16 GABELLI FUNDS LLC 2,000,000 2,274,000 0.92% PRN
17 UBS Group AG 2,000,000 2,274,000 0.92% PRN
18 Context Capital Management, LLC 1,500,000 1,730,000 0.70% PRN
19 Rock Springs Capital Management LP 1,500,000 1,713,000 0.69% PRN
20 Mohican Financial Management, LLC 1,000,000 1,137,000 0.46%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.